Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel-Reference-Cited by-同舟云学术

Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel

Published:2011-06-24 Issue:1 Volume:54 Page:79-90
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Foster Toshana L.,Verow Mark,Wozniak Ann L.,Bentham Matthew J.,Thompson Joseph,Atkins Elizabeth,Weinman Steven A.,Fishwick Colin,Foster Richard,Harris Mark,Griffin Stephen

Publisher

Wiley

Subject

Hepatology

Reference50 articles.

1. Therapy of hepatitis C: from empiricism to eradication;Pawlotsky;HEPATOLOGY,2006

2. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome;Wakita;Nat Med,2005

3. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome;Choo;Science,1989

4. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus;Jones;J Virol,2007

5. Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions;Steinmann;PLoS Pathog,2007

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing the field of viroporins—Structure, function and pharmacology: IUPHAR Review 39;British Journal of Pharmacology;2024-09-03

2. Compounds based on Adamantyl-substituted Amino Acids and Peptides as Potential Antiviral Drugs Acting as Viroporin Inhibitors;Current Pharmaceutical Design;2024-04

3. COVID-19 ORF3a Viroporin-Influenced Common and Unique Cellular Signaling Cascades in Lung, Heart, and the Brain Choroid Plexus Organoids with Additional Enriched MicroRNA Network Analyses for Lung and the Brain Tissues;ACS Omega;2023-11-17

4. COVID-19 ORF3a Viroporin Influenced Common and Unique Cellular Signalling Cascades in Lung, Heart and Brain Choroid Plexus Organoids with Additional Enriched MicroRNA Network Analyses for Lung and Brain Tissues;2023-09-21

5. SPCS1-Dependent E2-p7 processing determines HCV Assembly efficiency;PLOS Pathogens;2022-02-07